Advancing workforce diversity by leveraging the Clinical and Translational Science Awards (CTSA) program.

CTSA Diversity clinical trials training workforce

Journal

Journal of clinical and translational science
ISSN: 2059-8661
Titre abrégé: J Clin Transl Sci
Pays: England
ID NLM: 101689953

Informations de publication

Date de publication:
2023
Historique:
received: 23 05 2022
revised: 18 10 2022
accepted: 19 10 2022
entrez: 27 2 2023
pubmed: 28 2 2023
medline: 28 2 2023
Statut: epublish

Résumé

Clinical trials continue to disproportionately underrepresent people of color. Increasing representation of diverse backgrounds among clinical research personnel has the potential to yield greater representation in clinical trials and more efficacious medical interventions by addressing medical mistrust. In 2019, North Carolina Central University (NCCU), a Historically Black College and University with a more than 80% underrepresented student population, established the Clinical Research Sciences Program with support from the Clinical and Translational Science Awards (CTSA) program at neighboring Duke University. This program was designed to increase exposure of students from diverse educational, racial, and ethnic backgrounds to the field of clinical research, with a special focus on health equity education. In the first year, the program graduated 11 students from the two-semester certificate program, eight of whom now hold positions as clinical research professionals. This article describes how leveraging the CTSA program helped NCCU build a framework for producing a highly trained, competent, and diverse workforce in clinical research responsive to the call for increased diversity in clinical trial participation.

Identifiants

pubmed: 36845302
doi: 10.1017/cts.2022.489
pii: S2059866122004897
pmc: PMC9947598
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e30

Informations de copyright

© The Author(s) 2022.

Références

Nat Commun. 2014 Oct 20;5:5260
pubmed: 25327703
Future Oncol. 2021 Aug;17(24):3271-3280
pubmed: 34047192
PLoS Med. 2015 Dec 15;12(12):e1001918
pubmed: 26671224
J Health Soc Behav. 2002 Sep;43(3):296-306
pubmed: 12467254
Ther Innov Regul Sci. 2020 Jan;54(1):1-20
pubmed: 32008235
Chest. 2006 Jan;129(1):15-26
pubmed: 16424409
J Clin Pharmacol. 2022 Apr;62(4):486-493
pubmed: 34608640

Auteurs

Tracie Locklear (T)

Biomanufacturing Research Institute and Technology Enterprise, Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, USA.

Roslyn Lewis (R)

Biomanufacturing Research Institute and Technology Enterprise, Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, USA.

Faye Calhoun (F)

Partnerships and Collaborative Agreements, North Carolina Central University, Durham, NC, USA.

Andy Li (A)

Biomanufacturing Research Institute and Technology Enterprise, Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, USA.

Kathryn C Dickerson (KC)

Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.

Amanda McMillan (A)

Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.

Lisa Davis (L)

Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.

Kafui Dzirasa (K)

Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
Howard Hughes Medical Institute, Chevy Chase, MD, USA.

Kevin P Weinfurt (KP)

Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.

Steven C Grambow (SC)

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.

Classifications MeSH